Literature DB >> 28536128

Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus.

Nicola Goldberg1, Michael Fralick2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28536128      PMCID: PMC5436963          DOI: 10.1503/cmaj.161455

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.

Authors:  Despoina Vasilakou; Thomas Karagiannis; Eleni Athanasiadou; Maria Mainou; Aris Liakos; Eleni Bekiari; Maria Sarigianni; David R Matthews; Apostolos Tsapas
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

Review 2.  Drug-drug interactions with sodium-glucose cotransporters type 2 (SGLT2) inhibitors, new oral glucose-lowering agents for the management of type 2 diabetes mellitus.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2014-04       Impact factor: 6.447

Review 3.  Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Jason H Y Wu; Celine Foote; Juuso Blomster; Tadashi Toyama; Vlado Perkovic; Johan Sundström; Bruce Neal
Journal:  Lancet Diabetes Endocrinol       Date:  2016-03-18       Impact factor: 32.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.